The results of genetic analysis and clinical outcomes after stent deployment in adult patients with isolated peripheral pulmonary artery stenosis

Misaki Kanezawa; Hiroto Shimokawahara; Masahiro Tsuji; Kazuki Suruga; Ayane Miyagi; Minako Marunaka; Takashi Mukai; Takahisa Kawaguchi; Ta-Yu Yang; Izumi Yamaguchi; Masao Nagasaki; Fumihiko Matsuda; Hiromi Matsubara

doi:10.1183/13993003.01511-2023

The results of genetic analysis and clinical outcomes after stent deployment in adult patients with isolated peripheral pulmonary artery stenosis

Eur Respir J. 2023 Dec 21;62(6):2301511. doi: 10.1183/13993003.01511-2023. Print 2023 Dec.

Authors

Affiliations

¹ Department of Cardiology, National Hospital Organization Okayama Medical Center, Okayama, Japan.
² Department of Cardiology, National Hospital Organization Okayama Medical Center, Okayama, Japan hiroto.shimokk@gmail.com.
³ Department of Radiology, National Hospital Organization Okayama Medical Center, Okayama, Japan.
⁴ Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
⁵ Human Biosciences Unit for the Top Global Course, Center for the Promotion of Interdisciplinary Education and Research (CPIER), Kyoto University, Kyoto, Japan.

Abstract

The RNF213 p.Arg4810Lys mutation is closely linked to the development of PPAS. Stent deployment might be a promising treatment option, but further investigation would be warranted. https://bit.ly/40t8Gmz

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Humans
Pulmonary Artery
Stenosis, Pulmonary Artery* / genetics
Stents
Treatment Outcome